Eli Lilly announces a $15 billion share buyback, three times its previous largest program, highlighting strong financial ...

Amid new worries that legal copycats of the weight-loss drugs from Eli Lilly and Novo Nordisk could erode the market for the ...

Companies competing in the pharmaceutical space are in the business of developing innovative treatments to combat illness and ...

Indianapolis-based Eli Lilly and Company announced Thursday that it is planning a $3 billion expansion of its manufacturing facility in Kenosha County, Wisconsin.

Eli Lilly will launch Mounjaro in India in 2025. The drug treats type 2 diabetes and obesity. Lilly received marketing ...

The purchase price of the facility was not disclosed, but Lilly says its new $3 billion investment – part of $23 billion ...

Eli Lilly plans a $3 billion expansion in Pleasant Prairie, Wis. and will create 750 full time jobs and 2,000 construction ...

Eli Lilly and Company announced Thursday a $3 billion expansion of its manufacturing operations in Kenosha County, which it ...